NCT00125164View on ClinicalTrials.gov

Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficiency

PHASE3CompletedINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Growth DisordersInsulin-Like Growth Factor-1 Deficiency
Interventions
DRUG

rhIGF-1 (mecasermin, Tercica, Inc.)

Twice Daily Injection

Trial Locations (1)

94005

Ipsen (formerly Tercica), Brisbane

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY